March 2012
Volume 53, Issue 14
Free
ARVO Annual Meeting Abstract  |   March 2012
Crossed Linked Actin Networks are Formed in Human Trabecular Meshwork Cells after treatment with Latrunculin B
Author Affiliations & Notes
  • Paul Russell
    School of Veterinary Medicine,
    University of California Davis, Davis, California
  • Kaitlin Murphy
    School of Biomedical Engineering,
    University of California Davis, Davis, California
  • Joshua A. Wood
    School of Veterinary Medicine,
    University of California Davis, Davis, California
  • Clayton T. McKee
    School of Veterinary Medicine,
    University of California Davis, Davis, California
  • Christopher J. Murphy
    School of Medicine and School of Veterinary Medicine,
    University of California Davis, Davis, California
  • Footnotes
    Commercial Relationships  Paul Russell, None; Kaitlin Murphy, None; Joshua A. Wood, None; Clayton T. McKee, None; Christopher J. Murphy, None
  • Footnotes
    Support  National Institutes of Health R01EY019475 and P30EY12576, National Glaucoma Research, a program of the American Health Assistance Foundation and Research to Prevent Blindness
Investigative Ophthalmology & Visual Science March 2012, Vol.53, 6946. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Paul Russell, Kaitlin Murphy, Joshua A. Wood, Clayton T. McKee, Christopher J. Murphy; Crossed Linked Actin Networks are Formed in Human Trabecular Meshwork Cells after treatment with Latrunculin B. Invest. Ophthalmol. Vis. Sci. 2012;53(14):6946.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Crossed Linked Actin Networks (CLANs) have been reported in cells in the trabecular meshwork of individuals with glaucoma. CLANs have also been reported in approximately 5% of confluent human trabecular meshwork (HTM) cells in vitro. The number of cells with CLANs increases dramatically after treatment of HTM cells with dexamethasone for 10 days. Latrunculin B (Lat B), a compound that disrupts the actin cytoskeleton of cells, reduces intraocular pressure and is in development as a treatment for glaucoma. Our lab has determined that approximately 90 minutes after treatment of HTM cells with Lat B, the cell stiffness is increased above pre-treatment values and returns to pre-treatment values after six hours. We wished to determine if CLANs were formed in these cells as a result of cytoskeleton rearrangement potentially contributing to the dynamic changes observed in cell stiffness.

Methods: : Cells at low cell density were treated with 2 micromolar Lat B for 30 minutes or with vehicle (DMSO) alone. Cells were fixed after removal of the drug at 30, 50, 90, 120 and 270 minutes and stained for actin using fluorescently labeled phalloidin and DAPI. Cells were imaged and analyzed for the presence of CLANs.

Results: : Five percent of the HTM cells prior to Lat B treatment were positive for CLANs. After Lat B treatment, the number of cells containing CLANs increased with time and reached 40% at 90 minutes. The number of cells with CLANs after 270 minutes was higher (12%) than the number in the control cells. The number of CLANs in cells treated with just vehicle alone remained at approximately 5% throughout the experiment.

Conclusions: : This is the first demonstration that CLANs can be present in non-confluent single HTM cells without extended treatment with dexamethasone. The percent of CLANs in HTM cells was similar to that reported after dexamethasone treatment. The peak of cells containing CLANs occurred at a similar time as the increase in cell stiffness measured in living HTM cells after Lat B treatment. This suggests that the increase in cell stiffness after Lat B treatment is correlated to the presence of CLANs. This represents the first demonstration that CLANs and CLAN formation can be studied in single cells in a short time frame.

Keywords: trabecular meshwork • cytoskeleton • drug toxicity/drug effects 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×